| Issue |
Section |
Title |
File |
| Vol 15, No 2S (2008) |
Articles |
Effektivnost' i bezopasnost' lapatiniba v kombinatsii s kapetsitabinom pri lechenii bol'nykh HER-2 pozitivnym metastaticheskim rakom molochnoy zhelezy |
|
| Vol 19, No 18 (2012) |
Articles |
Adjuvant therapy with trastuzumab for early-stage breast cancer: 12 or 24 months (based on ESMO data, Vienna, october, 2012) |
|
| Vol 20, No 17 (2013) |
Articles |
Refnot® – novyy immunomodulyator dlya lecheniya onkologicheskikh bol'nykh |
|
| Vol 22, No 8 (2015) |
Articles |
Perspektivy primeneniya kapsul vinorelbina v sovremennoy onkologii |
|
| Vol 22, No 18 (2015) |
Articles |
Kadsila (trastuzumab emtanzin, T-DM1): pervyy kon\"yugat antitela i khimiopreparata v lechenii HER2-polozhitel'nogo raka molochnoy zhelezy |
|
| Vol 22, No 18 (2015) |
Articles |
15-letniy opyt ispol'zovaniya Gertseptina pri HER2-pozitivnom rake molochnoy zhelezy |
|
| Vol 22, No 18 (2015) |
Articles |
Klinicheskiy sluchay uspeshnogo lecheniya HER-pozitivnogo disseminirovannogo raka zheludka s polnym i prodolzhitel'nym effektom |
|
| Vol 23, No 17 (2016) |
Articles |
RESOLUTION SUMMARIZING THE RESULTS OF THE EXPERT COUNCIL "MODERN APPROACHES TO THE TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER. PROSPECTS FOR THE USE OF ERIBULIN AS A PART OF COMBINATION THERAPY FOR BREAST CANCER" |
|